NEWSpublisher 2007 :: AngloChinese Investments
SEARCH NEWS
date from:
date to:
company:
search for string:
NEWS SECTIONS
COMPANY GROUPS
TOP NEWS
» 23/07/2009 [Company watch]
China Aoxing Pharmaceutical Corp. Receives Renewal of GMP Certification for Capsule Dosage Form of Pharmaceutical Products
» 15/03/2010 [Industry news]
Recordati S.p.A And Lee Pharmaceutical Announce Partnership For Zanidip(R) In China
» 26/10/2009 [Finance]
China Growth to Remain Fast in Fourth Quarter, Official Says
» 17/08/2009 [Industry news]
Chindex Posts Profit on Product Sales, Health Services
» 07/05/2010 [Industry news]
Hong Kong: Recall of all products manufactured by Quality Pharmaceutical Lab Ltd
COMPANY NEWS » TOP China Pharmas back to previous page show list
3SBIO (Shenyang Sunshine) »03/11/2007 [Company watch]
3SBio takes lion share in China's EPO market

Recombinant human erythropoietin (EPO) injection product Epiao of Shenyang Sunshine Pharmaceutical Co., Ltd. (3Sbio, SSRX.NASDAQ) has seen brisk sales and now takes a market share of 37 percent in China.

 

Meanwhile, Amgen Corporation's Espo and Roche Corporation's Recormon have a share of 15 percent and 10 percent respectively in the Chinese market.

In part, this results from much lower price of Epiao, which, however, boasts 90 percent profit margin and makes up 70 percent of 3Sbio's sales revenue with annual growth rate of 30 percent.Since 1999, seven million units of Epiao have been marketed and currently Epiao is available in 800 large hospitals nationwide and the figure is expected to rise to over 920 by the end of 2007.

Plus, 3Sbio's recombinant human thrombopoietin injection product Tpiao, launched in 2006, posted sales revenue of 1.3 million U.S. dollars in the second accounting quarter, up 263 percent year-on-year.

3Sbio also plans to sell Epiao in European markets by 2011 and have six new candidate drugs for human papilloma virus vaccine.

The company has just released its second quarter financial statement reporting sales revenue of 5.7 million U.S. dollars, up 49. 2 percent year on year.

 

 


AngloChinese Investments ltd.
Home | Company news | TOP 50 | Events | About us
C&F Bright Solutions ltd.